由于支气管石病的粘膜损伤,其临床表现模仿过敏性支气管肺性阿斯伯吉洛症
Michihiro Kunishige1,2, Hiroki Takahashi1, Kiyohide Takahashi1
1Division of Internal Medicine, Japan Agricultural Cooperatives Kochi Hospital, Nankoku, Japan.
概括
在严重的喘病例中,应考虑支气管结石病,这是一种罕见的粘膜损伤原因. 这种情况可以模仿过敏性支气管肺性阿斯伯吉洛症 (ABPA),并加剧喘症状.
科学领域:
- 肺部病理学 肺部病理学
- 医疗成像医学成像
- 过敏和免疫学 过敏和免疫学
背景情况:
- 粘膜损伤是区分严重喘的一个关键特征,特别是过敏性支气管肺性阿斯伯吉洛症 (ABPA).
- 准确的诊断对于有效的喘管理和治疗策略至关重要.
研究的目的:
- 突出支气管结石病作为严重喘时粘膜损伤的罕见原因.
- 强调在分辨诊断粘膜损伤时考虑支气管结石病的重要性,特别是当怀疑ABPA时.
主要方法:
- 一个62岁的男子患有严重喘并呈阳性抗阿斯伯吉卢斯IgG抗体的病例报告.
- 诊断评估,包括成像检查,以确定喘息和粘膜损伤的原因.
主要成果:
- 患者的喘息和粘膜损伤最终归因于支气管石,而不是ABPA.
- 支气管石可以导致气道狭窄和粘膜损伤,可能加剧喘.
结论:
- 支气管结石病是一种罕见但重要的粘膜损伤原因.
- 支气管结石病应被纳入患者的差异诊断的粘膜损伤和严重的喘,即使在存在的真菌敏感化标志物.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Cystic Fibrosis: Pathogenesis
196
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
196
Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215


